GLP-1 medications should not be taken by anyone with a personal history or family history of medullary thyroid cancer, as development of these tumors were noted during early animal studies
Preclinical studies demonstrated that GLP-1 receptor agonists increased bone formation and reduced bone resorption in metabolic bone disease models, including diabetic osteoporosis, postmenopausal osteoporosis, and glucocorticoid-induced osteoporosis
Protective effect of caffeic acid on cardiac markers and lipid peroxide metabolism in cardiotoxic rats: an in vivo and in vitro study
No the medications themselves are compounded , which means they are not FDA-approved
But buying GLP-1 medications in Mexico is not as simple as walking into a Walgreens south of the border
L-carnitine (1,000 mg/day) and inulin (10,000 mg/day) produced small reductions of 0.32 and 0.12, respectively, while vitamin B (10,000 mg/day) showed a minimal increase (0.20), and LC n3-PUFA (6,000 mg/day) was associated with an increase of 0.64